Attention: open in a new window. E-mailPrintPDF
Drug manufacturers investing in Poland can count on PLN400m in support from a new developmental reimbursement scheme (RTR). The work on RTR started already in 2016 as part of cooperation…

Order subscription to read this article




Order at
Order from our partners:

Call us:

Find us: